JGC
MRK icon

J. Goldman & Co’s Merck MRK Stock Holding History

J. Goldman & Co’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-17,518
Closed -$1.57M – 573
2025
Q1 		$1.57M Sell
17,518
-56,437
-76% -$5.27M 0.04% 324
2024
Q4 		$7.36M Sell
73,955
-184,951
-71% -$19.1M 0.19% 161
2024
Q3 		$29.4M Sell
258,906
-386,730
-60% -$45.9M 0.82% 28
2024
Q2 		$79.9M Buy
645,636
+309,797
+92% +$39.9M 2.26% 3
2024
Q1 		$44.3M Buy
335,839
+163,811
+95% +$20.2M 1.43% 11
2023
Q4 		$18.8M Sell
172,028
-131,167
-43% -$13.6M 0.76% 44
2023
Q3 		$31.2M Buy
+303,195
New +$32.7M 1.09% 25
2023
Q2 		– Sell
-135,428
Closed -$15.4M – 453
2023
Q1 		$14.4M Buy
+135,428
New +$14.6M 0.58% 49
2022
Q4 		– Sell
-35,877
Closed -$3.09M – 450
2022
Q3 		$3.09M Buy
+35,877
New +$3.2M 0.15% 167
2021
Q4 		– Sell
-36,166
Closed -$2.72M – 403
2021
Q3 		$2.72M Buy
+36,166
New +$2.75M 0.14% 169
2021
Q2 		– Sell
-2,737
Closed -$201K – 469
2021
Q1 		$201K Buy
+2,737
New +$202K 0.01% 400
2020
Q4 		– Sell
-84,822
Closed -$6.71M – 451
2020
Q3 		$6.71M Buy
+84,822
New +$6.64M 0.45% 68
2017
Q1 		– Sell
-5,345
Closed -$300K – 382
2016
Q4 		$300K Buy
+5,345
New +$313K 0.02% 270
2013
Q3 		– Sell
-83,840
Closed -$3.72M – 296
2013
Q2 		$3.72M Buy
+83,840
New +$3.74M 0.38% 83

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

J. Goldman & Co's MRK Position: Q2 2025 in Review

J. Goldman & Co sold out of Merck (MRK) in Q2 2025, closing a stake of 17,518 shares — an estimated $1.57M sold.

J. Goldman & Co first reported a position in MRK in Q2 2013 and held it in 14 quarters. The position peaked at $79.9M in Q2 2024. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • J. Goldman & Co reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
  • J. Goldman & Co sold 17,518 Merck shares in Q2 2025, an estimated $1.57M.
  • J. Goldman & Co first reported a position in Merck in Q2 2013 and held it in 14 quarters.
  • J. Goldman & Co's Merck position peaked at $79.9M in Q2 2024.
  • 3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on J. Goldman & Co's 13F filing for Q2 2025, filed 14 Aug 2025.